Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
50.28M | 68.68M | 48.93M | 30.66M | 15.45M | 41.05M | Gross Profit |
13.87M | 23.54M | 15.70M | 10.35M | 5.66M | 9.90M | EBIT |
-11.44M | -19.94M | -5.74M | -1.10M | -2.52M | -3.04M | EBITDA |
-28.47M | -16.67M | -5.25M | -1.12M | -1.46M | 150.80K | Net Income Common Stockholders |
-35.04M | -30.01M | -10.80M | -3.72M | -3.03M | -3.38M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
0.00 | 1.04M | 1.36M | 1.38M | 1.39M | 238.76K | Total Assets |
27.88K | 39.37M | 45.48M | 47.01M | 19.24M | 19.23M | Total Debt |
15.07K | 38.50M | 29.65M | 32.35M | 7.92M | 13.84M | Net Debt |
15.07K | 37.73M | 28.57M | 30.97M | 6.52M | 13.60M | Total Liabilities |
38.54K | 59.41M | 42.59M | 45.45M | 15.99M | 23.23M | Stockholders Equity |
-10.67K | -18.73M | 2.60M | 1.47M | 4.13M | -3.96M |
Cash Flow | Free Cash Flow | ||||
-11.33M | -7.78M | -4.39M | -1.25M | 3.77M | -2.11M | Operating Cash Flow |
-11.32M | -7.54M | -4.13M | -1.07M | 3.93M | -1.92M | Investing Cash Flow |
17.51M | -3.89M | -160.42K | -15.04M | 1.13M | -47.32K | Financing Cash Flow |
2.57M | 11.12M | 3.99M | 16.38M | 4.63M | 1.88M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $123.91B | 21.94 | 33.10% | 2.31% | 5.05% | 2.73% | |
74 Outperform | $66.17B | 19.26 | 110.24% | 2.62% | -1.30% | 20.26% | |
70 Outperform | $179.04B | 27.92 | 27.62% | 0.89% | -32.60% | -28.55% | |
65 Neutral | $130.05B | 34.37 | 7.57% | 0.62% | -13.50% | -17.25% | |
64 Neutral | $68.44B | 16.80 | 97.86% | 2.23% | -18.72% | ― | |
62 Neutral | $7.24B | 12.39 | 3.08% | 3.39% | 3.63% | -14.35% | |
22 Underperform | $1.88M | ― | 143.20% | ― | -43.95% | 95.23% |
On March 11, 2025, 1847 Holdings LLC amended its Second Amended and Restated Operating Agreement to increase the number of authorized common shares from 500 million to 2 billion. Additionally, the 2023 Equity Incentive Plan was amended to increase the share reserve to 5 million common shares. These changes were approved by the Board of Directors on December 30, 2024, and by shareholders on March 11, 2025, during a special meeting. The meeting also saw the redemption of series E preferred shares and approval of several proposals, including adjustments to warrant exercise prices and the potential adjournment of the meeting if necessary. This expansion in share authorization and equity plan adjustments is likely to impact the company’s capital structure and shareholder value.